The combined use of arginine and glutamine in enteral and parenteral nutrition for patients after gastric cancer surgery has led to increased levels of albumin, serum protein, and transferrin, as well as decreased levels of C-reactive protein, C3, and C4 [30]. The gene discussed is C3; the disease is gastric cancer.